Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.750
-0.140-2.38%
Volume:10.32M
Turnover:58.87M
Market Cap:9.18B
PE:-18.27
High:5.890
Open:5.890
Low:5.500
Close:5.890
52wk High:13.150
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:1.17
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.41%
PB:6.09
PE(LYR):-18.27
PS:18.50

Loading ...

CStone Plans First Wave of Global Phase III Trials for Cs2009 by End-2026

Reuters
·
Yesterday

CStone Says Pralsetinib Sales Volume Jumps Nearly 500% After China NRDL Listing

Reuters
·
Yesterday

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Yesterday

China's Zhaoke Ophthalmology H1 Revenue Rises

Reuters
·
Aug 28

CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy

Simply Wall St.
·
Aug 28

New Zealand's Rua Bioscience FY Customer Revenue Jumps on Australia, NZ Growth

Reuters
·
Aug 28

CStone Pharmaceuticals Posts HY Loss of Rmb252.3 Million

Reuters
·
Aug 27

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

Cstone Pharma-B Reports Interim Results with Revenue Surging 314.75% to RMB 205 Million

Stock News
·
Aug 27

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

Reuters
·
Aug 27

CStone Pharmaceuticals - no Dividends Paid, Declared or Proposed During Interim Period

THOMSON REUTERS
·
Aug 27

CStone 1H FY26 Loss Narrows to RMB 252.28 Million; Revenue Rises to RMB 205.1 Million

Reuters
·
Aug 27

CStone Pharmaceuticals H1 Revenue RMB 205.1 Million

THOMSON REUTERS
·
Aug 27

When Will CStone Pharmaceuticals (HKG:2616) Breakeven?

Simply Wall St.
·
Aug 27

CStone Pharmaceuticals' Application for Tumor Drug Gets China Nod in 23 Days

MT Newswires Live
·
Aug 21

CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application

Stock News
·
Aug 21

CStone Says China NMPA Clears IND for Cs5007 Egfr/her3 Bispecific ADC

Reuters
·
Aug 21

CStone Pharmaceuticals - Receives Nmpa Ind Approval for Cs5007 in China

THOMSON REUTERS
·
Aug 21

CStone Pharma Cuts Outstanding Shares by 4.47 Million in July; Confirms Public-Float Compliance

Bulletin Express
·
Aug 06